Abbott Laboratories: There May Be A Surge Coming Next Week (Earnings Preview) [Seeking Alpha]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Seeking Alpha
Abbott's Q2 results showed strong earnings growth, but the stock fell due to expectations of a bigger beat. The company is building a defensible position in the diabetes ecosystem, moving beyond devices to data-driven, integrated care solutions. Abbott trades at a P/E of 16.8x, well below its historical average and the healthcare sector median, suggesting undervaluation. The key risk is high competition in its core growth areas, but successful execution could yield outsized long-term shareholder returns. jetcityimage/iStock Editorial via Getty Images Abbott Laboratories ( NYSE: ABT ) is expected to report its Q3 earnings on Wednesday, next week. Back when the company released its previous results, FY25'Q2, on the 17th of July, ABT stock dropped almost 9%, from $131 to $120. This selloff had come, despite Abbott This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to in
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- How Investors May Respond To Abbott (ABT) Missing Q3 Revenue Targets While Reaffirming Outlook and Buying Back Shares [Yahoo! Finance]Yahoo! Finance
- Preliminary tests find germ that causes botulism in ByHeart baby formula [Los Angeles Times (CA)]Los Angeles Times
- Preliminary tests find germ that causes botulism in ByHeart baby formula [CNN]CNN
- Preliminary tests find germ that causes botulism in ByHeart baby formula [CNN]CNN
- Has Abbott Stock's Valuation Shifted With Expanded FDA Approvals in 2025? [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 10/15/25 - In-Line
ABT
Sec Filings
- 10/29/25 - Form 10-Q
- 10/15/25 - Form 8-K
- 10/2/25 - Form 4
- ABT's page on the SEC website